SeaStar Medical Holding Corporation (ICU)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Eric Schlorff
|
CEO, Treasurer, President & Executive Director | 406.5k | -- | 1973 |
|
Mr. Michael Messinger CPA
|
Chief Financial Officer | 30k | -- | 1975 |
|
Colonel Kevin Chung FACP, M.D.
|
Chief Medical Officer | 345k | -- | 1973 |
|
Dr. H. David Humes M.D.
|
Co-Founder & Scientific Advisor | 135.71k | -- | -- |
|
Mr. Tom Mullen
|
Vice President of Operations & Product Development | -- | -- | -- |
|
Mr. Bradford K. Towne CPA
|
Controller & Principal Accounting Officer | -- | -- | 1978 |
|
Mr. Tim Varacek
|
Senior Vice President of Commercial & Business Operations | -- | -- | -- |
|
Mr. Sai P. Iyer Ph.D.
|
Senior Vice President of Medical Affairs & Research | -- | -- | -- |
SeaStar Medical Holding Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 18
Description
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
